Chemotaxis of human neutrophils and monocytes was stimulated by sera activated with -1.25 x 106 Crvptococclus neofoimnans. Leukocytes from five renal transplant recipients had depressed chemotactic responses to C. neoformans-activated sera when compared with normal subjects (P < 0.05). Concentrations of cryptococcal capsular polysaccharide less than I mg/ml failed to generate chemotactic factors from sera.
Progressive infections caused by the encapsulated yeast Cryptococcuts neoformans are usually associated with a scanty host inflammatory response, especially in brain (8, 12) . C. neojormans activates the classical and alternative complement pathways in serum (5) , generating factors chemotactic for rabbit neutrophils (10) . Since human neutrophils and monocytes can kill C. neoformans (6) , the degree of host chemotactic response may play a critical role in determining the outcome of cryptococcosis in humans. Therefore, generation of chemotactic factors by whole C. neoformans was studied, as well as effects of cryptococcal capsular polysaccharide on the process. To explore the potential biological significance of the process, results were compared by using leukocytes from normal volunteer subjects as well as from patients with conditions which are known to predispose to cryptococcosis.
A type A isolate to C. neoformans was maintained and used for preparation of capsular polysaccharide as in previous studies (5) , as described by Bennett and Hasenclaver (1) . Sera, neutrophils, and monocytes were prepared as in previous studies (4, 6 In five experiments, 2 mg of cryptococcal capsular polysaccharide per ml of sera induced a modest increment in neutrophil migration (chemotactic index 1.61 ± 0.21, P < 0.05); 1 mg of polysaccharide stimulated monocyte chemotaxis (1.50 ± 0.18, P < 0.02). Neither lower polysaccharide concentrations in serum nor polysaccharide or whole yeasts in the absence of serum were chemotactic. The presence of 1 mg of polysaccharide per ml of serum during activation by cryptococci combined with the addition of polysaccharide to incubations in the chemotactic chambers inhibited leukocyte migration (1.89 ± 0.12 versus 2.57 + 0.24, P < 0.05). However, inhibition of chemotaxis was not significant if the polysaccharide was added in these concentrations either only to the activation step or to the incubation with leukocytes. Thus, cryptococcal polysaccharide itself had minimal chemotactic activity, but when added to serum, it had the capacity to interfere with the normal, serum-dependent chemotactic response.
Hydrocortisone (210-4 M) inhibited chemotaxis by monocytes only when present both during serum activation and in both sides of chambers (2.57 ± 0.24 reduced to 1.230 ± 0.10, p < 0.01).
C. neoformans yeast cells presumably generated C5a from unheated human serum, stimulating chemotaxis of human neutrophils and monocytes. Laxalt and Kozel showed comparable results with neutrophils and sera from experimental animals (10) .
In contrast to intact C. neoformans, capsular polysaccharide generated chemotactic factors from sera only in high concentrations not generally found in cryptococcosis (3) , although documented in rare patients (13) . Higher concentrations of polysaccharide might cause even greater inhibitory effects, but the biological relevance of these effects would be questionable. Moreover, solutions of higher concentrations of polysaccharide have viscosities high enough to produce nonspecific effects on leukocyte function. Activation of complement by cryptococcal polysaccharide was described by Gadebusch (9) and then confirmed in this laboratory (5) by using polysaccharide prepared from a serotype A isolate. However, complement consumption in sera of cryptococcosis patients occurs only in association with fungemia (11), and Laxalt and Kozel noted no complement activation by ',1 mg/ml concentrations of polysaccharide prepared from a serotype D isolate (10) . Polysaccharide concentrations tested in our studies were higher, and currently available preparations of type A polysaccharide do activate complement, perhaps due to structural differences in the polysaccharides or to contamination with cell wall components (Thomas R. Kozel, personal communication). High concentrations of polysaccharide also inhibited the chemotactic response to cryptococcal cells in serum, similar to a phenomenon described by Drouhet and Segretain (7) .
Immunosuppression, especially with azathioprine, may inhibit the chemotactic response to cryptococci, as all five renal transplant recipients were receiving azathioprine but not necessarily pharmacological doses of corticosteroids. Hydrocortisone added in vitro inhibited chemotaxis by normal monocytes only in a 10-4 M concentration. The biological implications of these observations are limited by the small number of patients studied and the use of healthy, normal subjects as controls; therefore, these data are preliminary. Testing of additional subjects, including patients with different stages of Hodgkin's and other lymphomas who are receiv-ing different chemotherapeutic regimens, are needed. Abnormal chemotaxis has been associated with cutaneous anergy in cryptococcosis (14) , and chemotactic responsiveness of host cells may prove to be a major factor determining the outcome of cryptococcosis.
